Insider transactions

Philip M Pead

CIK 1227485 · President and CEO · last filed 2022-10-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$20.23M
Companies
5
Total Filings
45
Lifetime Open-Market Net
$2.40M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

PRGS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. — 8 joint filings, latest 2012-03-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Change Healthcare Inc. (CHNGU) Delisted Director 102,642 $73.71 $7.57M $0 5 2022-04-27
PRGS President and CEO 437,799 $46.22 $20.23M $1.01M 20 2017-04-04
Veradigm Inc. (MDRX) Delisted Chairman of the Board 294,312 $6.81 $2.00M $0 7 2012-03-27
Emdeon Inc. (EM) Delisted Director 36,880 $1.20 $44.1K $387.5K 5 2011-08-26
ECLIPSYS CORP (ECLP) Delisted CEO 136,179 — — $995.6K 5 2010-03-17

Recent Filings · Page 3 of 5

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-10-03 PRGS Tax (F) −15,888 -$413.1K EDGAR
2013-08-05 PRGS Tax (F) −203 -$5.2K EDGAR
2013-01-24 PRGS Grant (A) +301,480 $0 EDGAR
2012-05-31 PRGS Grant (A) +10,035 $0 EDGAR
2012-03-27 Veradigm Inc. (MDRX) Delisted Tax (F) −2,775 -$49.0K EDGAR
2012-03-19 Veradigm Inc. (MDRX) Delisted Mixed +21,297 -$78.4K EDGAR
2012-01-13 PRGS Buy (P) +28,000 $515.9K EDGAR
2011-10-26 Veradigm Inc. (MDRX) Delisted Mixed +15,888 -$236.5K EDGAR
2011-10-18 PRGS Grant (A) +14,472 $300.0K EDGAR
2011-08-26 Emdeon Inc. (EM) Delisted Mixed +5,685 $0 EDGAR
Showing 21–30 of 45
Page 3 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.